An analyst firm provided target price updates for Oruka Therapeutics, Inc. on June 6, 2026.
5 reports, 1 independent
Updated Thu 00:00
No new developments lately
- Reports
- 5
- Developments
- 2
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
An analyst firm provided target price updates for Oruka Therapeutics, Inc. on June 6, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Leerink Partners set a price objective on Oruka stock following a company filing to the SEC.1 source
Target price updates provided by an analyst firm for Oruka Therapeutics, Inc.1 source
Keep exploring
The entities involved
-
Leerink partners
U.S. investment bank
-
SEC
Slovak company
Related events
- An analyst firm has provided price target recommendations for Universal Health Services.
- Analyst firm Leerink partners raised the price target for Roivant based on share count forecast on August 13, 2025.
- Leerink raised its price target for UnitedHealth Group stock.
- Leerink Partners provided coverage and price targets for Freenome on September 26, 2026.
- Truist Financial and Leerink Partners raised price objectives for Eli Lilly and Company stock.